Advancements and challenges in brain cancer therapeutics

Author:

Bai Fan12,Deng Yueyang34,Li Long15,Lv Ming6,Razzokov Jamoliddin789,Xu Qingnan1,Xu Zhen1,Chen Zhaowei10,Chen Guojun34ORCID,Chen Zhitong12511

Affiliation:

1. Paul C Lauterbur Research Center for Biomedical Imaging, Institute of Biomedical and Health Engineering Shenzhen Institute of Advanced Technology Chinese Academy of Sciences Shenzhen China

2. Advanced Therapeutic Center National Innovation Center for Advanced Medical Devices Shenzhen China

3. Department of Biomedical Engineering McGill University Montreal Quebec Canada

4. Rosalind & Morris Goodman Cancer Institute McGill University Montreal Quebec Canada

5. University of Chinese Academy of Sciences Shenzhen Guangdong P. R. China

6. Department of Medical Engineering Medical Supplies Center of Chinese PLA General Hospital Beijing China

7. Institute of Fundamental and Applied Research National Research University TIIAME Tashkent Uzbekistan

8. Laboratory of Experimental Biophysics Centre for Advanced Technologies Tashkent Uzbekistan

9. Department of Biomedical Engineering Tashkent State Technical University Tashkent Uzbekistan

10. Institute of Food Safety and Environment Monitoring MOE Key Laboratory for Analytical Science of Food Safety and Biology College of Chemistry Fuzhou University Fuzhou China

11. Key Laboratory of Biomedical Imaging Science and System Chinese Academy of Sciences Shenzhen China

Abstract

AbstractTreating brain tumors requires a nuanced understanding of the brain, a vital and delicate organ. Location, size, tumor type, and surrounding tissue health are crucial in developing treatment plans. This review comprehensively summarizes various treatment options that are available or could be potentially available for brain tumors, including physical therapies (radiotherapy, ablation therapy, photodynamic therapy, tumor‐treating field therapy, and cold atmospheric plasma therapy) and non‐physical therapies (surgical resection, chemotherapy, targeted therapy, and immunotherapy). Mechanisms of action, potential side effects, indications, and latest developments, as well as their limitations, are highlighted. Furthermore, the requirements for personalized, multi‐modal treatment approaches in this rapidly evolving field are discussed, emphasizing the balance between efficacy and patient safety.

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Wiley

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3